Indication
Bleeding episode in hemophilia B
A bleeding episode in hemophilia B is an acute hemorrhagic event occurring in individuals with an inherited deficiency or dysfunction of coagulation factor IX, an essential serine protease in the intrinsic blood clotting cascade. Read more about Bleeding episode in hemophilia B
11 drugs 8 manufacturers
Drugs that treat it
Common Bleeding episode in hemophilia B therapies.
FEIBA NF (anti-inhibitor coagulant complex)
NOVOSEVEN RT (coagulation factor VIIa (recombinant))
FEIBA NF (anti-inhibitor coagulant complex)
FEIBA NF (anti-inhibitor coagulant complex)
FEIBA NF (anti-inhibitor coagulant complex)
SEVENFACT (coagulation factor VIIa recombinant-jncw)
IXINITY (factor IX human recombinant, threonine 148)
HEMGENIX (etranacogene dezaparvovec-drlb)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA bleeding episode in hemophilia B is an acute hemorrhagic event occurring in individuals with an inherited deficiency or dysfunction of coagulation factor IX, an essential serine protease in the intrinsic blood clotting cascade.
Primarily affecting males due to its X-linked recessive inheritance, the condition compromises thrombin generation and fibrin clot formation, predisposing patients to prolonged or spontaneous bleeding.
Clinically, these episodes manifest as bleeding provoked by trauma, surgery, or invasive procedures, or spontaneously in moderate-to-severe disease.
Hemorrhages most commonly involve the musculoskeletal system—particularly recurrent intra-articular bleeding (hemarthrosis) and deep intramuscular hematomas—as well as mucocutaneous tissues or, less frequently, life-threatening intracranial and gastrointestinal sites.
- medlineplus.gov
A bleeding episode in hemophilia B is an acute hemorrhagic event occurring in individuals with an inherited deficiency or dysfunction of coagulation factor IX, an essential serine protease in the intrinsic blood clotting cascade
- takedamedconnect.com
A bleeding episode in hemophilia B is an acute hemorrhagic event occurring in individuals with an inherited deficiency or dysfunction of coagulation factor IX, an essential serine protease in the intrinsic blood clotting cascade Primarily affecting males due to its X-linked recessive inheritance, the condition compromises thrombin generation and fibrin clot formation, predisposing patients to prolonged or spontaneous bleeding
- nih.gov
Primarily affecting males due to its X-linked recessive inheritance, the condition compromises thrombin generation and fibrin clot formation, predisposing patients to prolonged or spontaneous bleeding
- hemophilianewstoday.com
Clinically, these episodes manifest as bleeding provoked by trauma, surgery, or invasive procedures, or spontaneously in moderate-to-severe disease Hemorrhages most commonly involve the musculoskeletal system—particularly recurrent intra-articular bleeding (hemarthrosis) and deep intramuscular hematomas—as well as mucocutaneous tissues or, less frequently, life-threatening intracranial and gastrointestinal sites
Personalize your experience
Follow Bleeding episode in hemophilia B and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.